Acta Naturae, 2019, 11(4):42-53

DARPins: Promising Scaffolds for Theranostics.

Monoclonal antibodies are the classical basis for targeted therapy, but the development of alternative binding proteins has made it possible to use non-immunoglobulin proteins as targeting modules. The advantages of DARPins, scaffold proteins based on ankyrin repeats, over antibodies are as follows: small size, stability over a wide range of temperatures and pH values, low aggregation tendency, and ease of production in heterologous expression systems. The differences in the structure of the paratope of DARPin and antibodies broaden the spectrum of target molecules, while the ease of creating hybrid fusion proteins allows one to obtain bispecific and multivalent constructs. In this article, we summarize recent data on the development of therapeutic and imaging compounds based on DARPins.

IBCH: 8395
Ссылка на статью в журнале: http://www.actanaturae.ru/attachment.aspx?id=4321
Кол-во цитирований на 05.2024: 48
Данные статьи проверены модераторами 2020-01-31

Список научных проектов, где отмечена публикация

  1. Development of an address system based on anti-HER2 scaffolds and a barnase-barstar molecular pair for the multistep delivery of cytotoxins in the treatment of HER2-positive malignant tumors. (January 6, 2019 — December 31, 2023). Deyev S.M., Lebedenko E.N., Proshkina G.M., Shilova O.N.. Grant, RSF.